脂蛋白 (a) 血和心血管风险降低与伊可萨乙烯
Michael Szarek1, Deepak L Bhatt2, Michael Miller3
1Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA; CPC Clinical Research, Aurora, Colorado, USA; State University of New York, Downstate Health Sciences University, Brooklyn, New York, USA.
伊科萨乙烯 (IPE) 有效降低患有高脂蛋白[Lp[a]的人的心血管事件风险,无论Lp[a]水平如何. 这一发现对于治疗他类药物患者的残留心血管风险管理至关重要.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 升高的脂蛋白[Lp[a]是心血管事件的重要危险因素,即使控制了LDL胆固醇.
- 很少有治疗选择可以减轻这种残留风险.
- 伊科萨乙烯 (IPE) 是一种用于降低心血管风险的试验性药物.
研究的目的:
- 分析icosapent乙烯 (IPE) 在各种脂蛋白[Lp]水平的心血管益处.
- 评估IPE在减少不同Lp度的患者主要心血管不良事件 (MACE) 的疗效.
主要方法:
- 对REDUCE-IT试验的特异分析,该试验涉及8,179名接受他类药物治疗的参与者.
- 参与者患有高甘油和控制的LDL胆固醇.
- 随机选择IPE或安慰剂,分析Lp(a) 水平和MACE.
主要成果:
- 脂蛋白 (a) [Lp (a) ]度是主要心血管不良事件 (MACE) 的重要预测因素.
- 伊可萨乙烯 (IPE) 在所有分析的Lp(a) 水平上都显示出MACE的持续降低.
- 在Lp (a) ≥50 mg/dL和<50 mg/dL的子组中,IPE显著降低了第一个MACE.
结论:
- 基线脂蛋白 (a) [Lp (a) ] 度预示着主要心血管不良事件 (MACE) 的预后,在治疗他类药物时,患者的甘油三水平升高.
- 伊可萨乙烯 (IPE) 在Lp (a) 水平的范围内提供了一致的心血管风险降低.
- 对于患有升高的Lp(a) 和残留心血管风险的患者来说,IPE可能是一个有价值的治疗选择.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Cholesterol: Significance and Regulation
Considering cholesterol and...


